BioSpace News Archive

Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of their latest market research engagement for a pharma company.

Saul Priceman, Ph.D., City of Hope assistant professor in the Department of Hematology & Hematopoietic Cell Transplantation, and his research team have received a $9.28 million award from the California Institute for Regenerative Medicine (CIRM) to support a chimeric antigen receptor (CAR) T cell phase 1 clinical trial for the treatment of women with HER2-positive breast cancer that has spread to the brain.

LIG Solutions, a division of Lighthouse Insurance Group, and PeopleKeep, Inc., the leader in personalized benefits for small businesses, announced at ASAE19, the annual meeting & exposition of the American Society of Association Executives (ASAE) a partnership to provide complementary health benefits options to the members of associations, societies, and other affinity groups across the United States.

The Canadian Medical Association (CMA) is continuing its 2nd annual CMA Health Summit tomorrow to highlight and discuss how to scale up and harness technology to improve the health care system.

IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics, provided a business update and announced financial results for the second quarter ended June 30, 2019.

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced financial results and a business update for the second quarter ended June 30, 2019

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the acquisition of Cavion, Inc. through a merger with a Jazz subsidiary.

Intends to retire from the Board at the expiration of his current term in June 2020.

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, reports financial results for the three and six months ended June 30, 2019, and provides an update on its business progress.

The Department of Homeland Security finalized a new rule that will deter use of vital services for some immigrant populations.